Leading Innovative Vaccine/Bio Technology SK bioscienceFrom Prevention To Cure
Our Science & Technology
News SK bioscience´s COVID-19...
manufacturing facility obtains gmp certification f...More
News sk bioscience lists on kospi
sk bioscience ceo ahn jae-yong and other officials...More
News sk bioscience and cepi expand ...
cepi grants up to $14.2 million of funding to supp...More
News SK Bioscience - Novavax ? KDCA...
SK Bioscience obtained exclusive rights to manufac...More
The first flu vaccine developed by using the cell-culturing method in Korea. It can provide a large amount of vaccine in a short period of time, as this method can produce a large amount of specific cells which are necessary for cultivating viruses in advance. Furthermore, people with egg allergies can be inoculated at the same time.
The world’s first WHO PQ-certified Quadrivalent flu vaccine developed by next-generation technology. Cell culture-derived method reduces the possibility of mutations that can occur in the incubation process, and has a high preventive effect.
Prefilled syringe-typed shingles vaccine that increases convenience and stability. It is manufactured in a way that is gaining global attention due to its high convenience, accurate dosage, and prevention of contamination when preparing for injection.
The world’s second WHO PQ-certified chickenpox virus vaccine, it was developed in Korea through a process of cell culture, virus infection, and refinement using the latest sterile production system.
- SKY Cellflu prefilled syringe
- SKY Cellflu Quadrivalent prefilled syringe
- SKY Zoster Inj.
- SKY Varicella Inj.